Report: WHO Strategic Priorities on Antimicrobial Resistance
Antimicrobial resistance (AMR) poses a significant global threat of far-reaching proportions. It is estimated that drugresistant infections contribute to nearly 5 million deaths every year.
Unless we act now, common diseases will become untreatable and modern life-saving procedures riskier to perform. The economic impact of uncontrolled antimicrobial resistance will result in a dramatic rise in health expenditures and damage to food systems and livelihoods, leading to increasing levels of poverty
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.